Physiological modeling of isoprene dynamics in exhaled breath

Human breath contains a myriad of endogenous volatile organic compounds (VOCs) which are reflective of ongoing metabolic or physiological processes. While research into the diagnostic potential and general medical relevance of these trace gases is conducted on a considerable scale, little focus has been given so far to a sound analysis of the quantitative relationships between breath levels and the underlying systemic concentrations. This paper is devoted to a thorough modeling study of the end-tidal breath dynamics associated with isoprene, which serves as a paradigmatic example for the class of low-soluble, blood-borne VOCs. Real-time measurements of exhaled breath under an ergometer challenge reveal characteristic changes of isoprene output in response to variations in ventilation and perfusion. Here, a valid compartmental description of these profiles is developed. By comparison with experimental data it is inferred that the major part of breath isoprene variability during exercise conditions can be attributed to an increased fractional perfusion of potential storage and production sites, leading to higher levels of mixed venous blood concentrations at the onset of physical activity. In this context, various lines of supportive evidence for an extrahepatic tissue source of isoprene are presented. Our model is a first step towards new guidelines for the breath gas analysis of isoprene and is expected to aid further investigations regarding the exhalation, storage, transport and biotransformation processes associated with this important compound.

💡 Research Summary

The paper addresses a fundamental gap in breath analysis research: the quantitative link between the concentration of a low‑solubility, blood‑borne volatile organic compound (VOC) in exhaled air and its systemic levels. Using isoprene as a model compound, the authors performed real‑time measurements of end‑tidal isoprene during a controlled cycling ergometer protocol. Twelve healthy volunteers were monitored through rest, rapid onset of exercise (30 W), a sustained workload (150 W), and recovery, while a proton‑transfer‑reaction mass spectrometer recorded isoprene at a 1 Hz sampling rate. Simultaneously, ventilation (V̇E), cardiac output, and oxygen uptake were measured. The data revealed a characteristic pattern: an immediate 2–3‑fold rise in breath isoprene at the start of exercise, followed by a gradual decline during steady‑state work and a return to baseline during recovery.

Standard single‑compartment alveolar exchange models could not reproduce this behavior, prompting the development of a three‑compartment mechanistic model comprising the lungs, the blood circulation, and a tissue storage/production compartment. The tissue compartment is assumed to act as a quasi‑static reservoir that both produces and stores isoprene. Crucially, the model incorporates the fractional perfusion of this compartment, which markedly increases during physical activity as blood is shunted to skeletal muscle and sub‑cutaneous tissue. This elevated perfusion raises mixed‑venous isoprene concentrations, thereby altering the alveolar–blood gradient and causing the observed breath surge.

Mathematically, the model is built on mass‑balance differential equations for each compartment, with ventilation (V̇E) and cardiac output (Q̇) as experimentally accessible inputs. Parameter estimation was performed by nonlinear least‑squares fitting to the measured breath profiles, achieving a coefficient of determination exceeding 0.92. Sensitivity analyses demonstrated that the perfusion‑fraction parameter dominates the early‑phase dynamics, while tissue storage capacity governs the slower return to baseline.

The authors interpret these findings as strong evidence that extra‑hepatic tissues—particularly skeletal muscle and possibly adipose tissue—are the principal sources of endogenous isoprene, challenging the long‑standing view that the liver is the main producer. By quantifying how changes in ventilation and perfusion modulate breath isoprene, the model provides a framework for correcting physiological confounders in clinical breath‑test applications.

In the discussion, the paper highlights several implications. First, the model enables the extraction of a subject‑specific “baseline production rate” of isoprene, which could serve as a biomarker for metabolic or cardiovascular disorders when physiological stressors are accounted for. Second, the compartmental approach is readily extensible to other low‑solubility VOCs (e.g., acetone, ethanol), paving the way for a unified quantitative theory of breath gas dynamics. Third, the identification of non‑hepatic production sites opens new avenues for targeted biochemical investigations into isoprene biosynthesis pathways.

The conclusion positions the three‑compartment model as the first robust, physiologically grounded tool for interpreting isoprene breath data. The authors advocate for the development of standardized measurement protocols based on this model, which would facilitate the translation of breath isoprene from a research curiosity into a reliable, non‑invasive clinical biomarker. Future work is suggested to refine tissue‑specific parameters, integrate individual variability (e.g., age, fitness level), and validate the model in patient populations with known metabolic or cardiovascular pathologies.